Inhibitory effects of epigallocatechin gallate and its glucoside on the human intestinal maltase inhibition

Biotechnology and Bioprocess Engineering

Volumn 17, Issue 5, 2012, Pages 966-971

  Nguyen, Thi Thanh Hanh ^a   Jung, Sun Hwa ^a   Lee, Sun ^a   Ryu, Hwa Ja ^a   Kang, Hee Kyoung ^a   Moon, Young Hwan ^b   Kim, Young Min ^c   Kimura, Atsuo ^d   Kim, Doman ^a  

^a Chonnam National University   (South Korea)

^b Audubon Sugar Institute   (United States)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alpha glucosidase; EGCG; EGCG glucoside; Human intestinal maltase; Molecular docking

Indexed keywords

ALPHA-GLUCOSIDASE; EGCG; EGCG GLUCOSIDE; HUMAN INTESTINAL MALTASE; MOLECULAR DOCKING;

BIOTECHNOLOGY;

HYDROGEN BONDS;

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE GLUCOSIDE; HUMAN INTESTINAL MALTASE; MALTOSE; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; IC 50; IN VITRO STUDY; MOLECULAR DOCKING; MOLECULAR MODEL; PICHIA PASTORIS;

EID: 84871256196     PISSN: 12268372     EISSN: 19763816     Source Type: Journal    
DOI: 10.1007/s12257-012-0242-8     Document Type: Article

References (32)

1. Zaveri, N. T. (2006) Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sci. 78: 2073-2080.
2. Khan, N., F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3- gallate. Cancer Res. 66: 2500-2505.
3. Higdon, J. V. and B. Frei (2003) Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. 43: 89-143.
4. Yang, C. S. and X. Wang (2010) Green tea and cancer prevention. Nutr. Cancer. 62: 931-937.
5. Wolfram, S., Y. Wang, and F. Thielecke (2006) Anti-obesity effects of green tea: From bedside to bench. Mol. Nutr. Food Res. 50: 176-187.
6. Hamiltonmiller, J. M. T. (1995) Antimicrobial properties of tea (Camellia-Sinensis L). Antimicrob. Agents Chemother. 39: 2375-2377.
7. Shankar, S., S. Ganapathy, S. R. Hingorani, and R. K. Srivastava (2008) EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front. Biosci. 13: 440-452.
8. Kitao, S., T. Matsudo, M. Saitoh, T. Horiuchi, and H. Sekine(1995) Enzymatic syntheses of 2 stable (-)-epigallocatechin gallate-glucosides by sucrose phosphorylase. Biosci. Biotechnol. Biochem. 59: 2167-2169.
9. Moon, Y. H., J. H. Lee, J. S. Ahn, S. H. Nam, D. K. Oh, D. H. Park, H. J. Chung, S. Kang, D. F. Day, and D. Kim (2006) Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB. J. Agric. Food Chem. 54: 1230-1237.
10. Lee, K. M., M. Yeo, J. S. Choue, J. H. Jin, S. J. Park, J. Y. Cheong, K. J. Lee, J. H. Kim, and K. B. Hahm (2004) Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter. 9: 632-642.
11. Seo, E. S., J. Kang, J. H. Lee, G. E. Kin, G. J. Kim, and D. Kim (2009) Synthesis and characterization of hydroquinone glucoside using Leuconostoc mesenteroides dextransucrase. Enz. Microb. Technol. 45: 355-360.
12. Kim, G. E., J. H. Lee, S. H. Jung, E. S. Seo, S. D. Jin, G. J. Kim, J. Cha, E. J. Kim, K. D. Park, and D. Kim (2010) Enzymatic synthesis and characterization of hydroquinone galactoside using Kluyveromyces lactis Lactase. J. Agric. Food Chem. 58: 9492-9497.
13. Tadera, K., Y. Minami, K. Takamatsu, and T. Matsuoka (2006) Inhibition of alpha-glucosidase and alpha-Amylase by flavonoids. J. Nutr. Sci. Vitaminol. 52: 149-153.
14. Park, H., K. Y. Hwang, K. H. Oh, Y. H. Kim, J. Y. Lee, and K. Kim (2008) Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure. Bioorg. Med. Chem. 16: 284-292.
15. Rossi, E. J., L. Sim, D. A. Kuntz, D. Hahn, B. D. Johnston, A. Ghavami, M. G. Szczepina, N. S. Kumar, E. E. Sterchi, B. L. Nichols, B. M. Pinto, and D. R. Rose (2006) Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives. FEBS J. 273: 2673-2683.
16. Henrissat, B. and G. Davies (1997) Structural and sequencebased classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7: 637-644.
17. Ryu, H. J., E. S. Seo, H. K. Kang, Y. M. Kim, and D. Kim (2011) Expression, purification, and characterization of human intestinal maltase secreted from Pichia pastoris. Food Sci. Biotechnol. 20: 561-565.
18. Morris, G. M., D. S. Goodsell, R. S. Halliday, R. Huey, W. E. Hart, R. K. Belew, and A. J. Olson (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19: 1639-1662.
19. Hyun, E. K., H. Y. Park, H. J. Kim, J. K. Lee, D. Kim, and D. K. Oh (2007) Production of epigallocatechin gallate 7-O-Alpha-Dglucopyranoside (EGCG-G1) using the glucosyltransferase from Leuconostoc mesenteroides. Biotechnol. Prog. 23: 1082-1086.
20. Sim, L., R. Quezada-Calvillo, E. E. Sterchi, B. L. Nichois, and D. R. Rose (2008) Human intestinal maltase-glucoamylase: Crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. J. Mol. Biol. 375: 782-792.
21. Thi, T. H. N., H. J. Ryu, S. H. Lee, S. Hwang, J. Cha, V. Breton, and D. Kim (2011) Discovery of novel inhibitors for human intestinal maltase: Virtual screening in a WISDOM environment and in vitro evaluation. Biotechnol. Lett. 33: 2185-2191.
22. Nguyen, T. T., H. J. Woo, H. K. Kang, V. D. Nguyen, Y. M. Kim, D. W. Kim, S. A. Ahn, Y. Xia, and D. Kim (2012) Flavonoidmediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol. Lett. 31: 831-838.
23. Nguyen, T. T. H., H. J. Ryu, S. H. Lee, S. Hwang, V. Breton, J. H. Rhee, and D. Kim (2011) Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. Bioorg. Med. Chem. Lett. 21: 3088-3091.
24. Wallace, A. C., R. A. Laskowski, and J. M. Thornton (1995) Ligplot -A program to generate schematic diagrams of protein ligand interactions. Protein Eng. 8: 127-134.
25. de Melo, E. B., A. D. Gomes, and I. Carvalho (2006) alpha-And beta-glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 62: 10277-10302.
26. Li, T., J. W. Liu, X. D. Zhang, and G. Ji (2007) Antidiabetic activity of lipophilic (-)-epigallocatechin-3-gallate derivative under its role of alpha-glucosidase inhibition. Biomed. Pharmacother. 61: 91-96.
27. Toshima, A., T. Matsui, M. Noguchi, J. Qiu, K. Tamaya, Y. Miyata, T. Tanaka, and K. Tanaka (2010) Identification of alphaglucosidase inhibitors from a new fermented tea obtained by tearolling processing of loquat (Eriobotrya japonica) and green tea leaves. J. Agric. Food Chem. 90: 1545-1550.
28. Kamiyama, O., F. Sanae, K. Ikeda, Y. Higashi, Y. Minami, N. Asano, I. Adachi, and A. Kato (2010) In vitro inhibition of alphaglucosidases and glycogen phosphorylase by catechin gallates in green tea. Food Chem. 122: 1061-1066.
29. Wu, D., X. W. Yu, T. C. Wang, R. Wang, and Y. Xu (2011) High yield Rhizopus chinenisis prolipase production in Pichia pastoris: Impact of methanol concentration. Biotechnol. Bioproc. Eng. 16: 305-311.
30. Zhang, J. H., D. Wu, J. Chen, and J. Wu (2011) Enhancing functional expression of beta-glucosidase in Pichia pastoris by coexpressing protein disulfide isomerase. Biotechnol. Bioproc. Eng. 16: 1196-1200.
31. Xu, Z., M. C. Shih, and J. E. Poulton (2006) An extracellular exo-beta-(1,3)-glucanase from Pichia pastoris: Purification, characterization, molecular cloning, and functional expression. Protein Expr. Purif. 47: 118-127.
32. Cereghino, J. L. and J. M. Cregg (2000) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24: 45-66.